These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29581537)

  • 1. M
    Moran SP; Dickerson JW; Cho HP; Xiang Z; Maksymetz J; Remke DH; Lv X; Doyle CA; Rajan DH; Niswender CM; Engers DW; Lindsley CW; Rook JM; Conn PJ
    Neuropsychopharmacology; 2018 Jul; 43(8):1763-1771. PubMed ID: 29581537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel M
    Rook JM; Bertron JL; Cho HP; Garcia-Barrantes PM; Moran SP; Maksymetz JT; Nance KD; Dickerson JW; Remke DH; Chang S; Harp JM; Blobaum AL; Niswender CM; Jones CK; Stauffer SR; Conn PJ; Lindsley CW
    ACS Chem Neurosci; 2018 Sep; 9(9):2274-2285. PubMed ID: 29701957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M
    Grannan MD; Mielnik CA; Moran SP; Gould RW; Ball J; Lu Z; Bubser M; Ramsey AJ; Abe M; Cho HP; Nance KD; Blobaum AL; Niswender CM; Conn PJ; Lindsley CW; Jones CK
    ACS Chem Neurosci; 2016 Dec; 7(12):1706-1716. PubMed ID: 27617634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PF-06827443 Displays Robust Allosteric Agonist and Positive Allosteric Modulator Activity in High Receptor Reserve and Native Systems.
    Moran SP; Cho HP; Maksymetz J; Remke DH; Hanson RM; Niswender CM; Lindsley CW; Rook JM; Conn PJ
    ACS Chem Neurosci; 2018 Sep; 9(9):2218-2224. PubMed ID: 29683646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biased M
    Moran SP; Xiang Z; Doyle CA; Maksymetz J; Lv X; Faltin S; Fisher NM; Niswender CM; Rook JM; Lindsley CW; Conn PJ
    Sci Signal; 2019 Dec; 12(610):. PubMed ID: 31796631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse Effects on M
    Rook JM; Abe M; Cho HP; Nance KD; Luscombe VB; Adams JJ; Dickerson JW; Remke DH; Garcia-Barrantes PM; Engers DW; Engers JL; Chang S; Foster JJ; Blobaum AL; Niswender CM; Jones CK; Conn PJ; Lindsley CW
    ACS Chem Neurosci; 2017 Apr; 8(4):866-883. PubMed ID: 28001356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Approach to Discovering Novel Muscarinic M
    Kurimoto E; Matsuda S; Shimizu Y; Sako Y; Mandai T; Sugimoto T; Sakamoto H; Kimura H
    J Pharmacol Exp Ther; 2018 Jan; 364(1):28-37. PubMed ID: 29025977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of mGlu
    Ghoshal A; Moran SP; Dickerson JW; Joffe ME; Grueter BA; Xiang Z; Lindsley CW; Rook JM; Conn PJ
    ACS Chem Neurosci; 2017 Oct; 8(10):2254-2265. PubMed ID: 28679049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning.
    Shirey JK; Brady AE; Jones PJ; Davis AA; Bridges TM; Kennedy JP; Jadhav SB; Menon UN; Xiang Z; Watson ML; Christian EP; Doherty JJ; Quirk MC; Snyder DH; Lah JJ; Levey AI; Nicolle MM; Lindsley CW; Conn PJ
    J Neurosci; 2009 Nov; 29(45):14271-86. PubMed ID: 19906975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AC-260584, an orally bioavailable M(1) muscarinic receptor allosteric agonist, improves cognitive performance in an animal model.
    Bradley SR; Lameh J; Ohrmund L; Son T; Bajpai A; Nguyen D; Friberg M; Burstein ES; Spalding TA; Ott TR; Schiffer HH; Tabatabaei A; McFarland K; Davis RE; Bonhaus DW
    Neuropharmacology; 2010 Feb; 58(2):365-73. PubMed ID: 19835892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the binding site of novel selective positive allosteric modulators at the M
    Khajehali E; Valant C; Jörg M; Tobin AB; Conn PJ; Lindsley CW; Sexton PM; Scammells PJ; Christopoulos A
    Biochem Pharmacol; 2018 Aug; 154():243-254. PubMed ID: 29777683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M
    Lv X; Dickerson JW; Rook JM; Lindsley CW; Conn PJ; Xiang Z
    Neuropharmacology; 2017 May; 118():209-222. PubMed ID: 28336323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model.
    Ghoshal A; Rook JM; Dickerson JW; Roop GN; Morrison RD; Jalan-Sakrikar N; Lamsal A; Noetzel MJ; Poslusney MS; Wood MR; Melancon BJ; Stauffer SR; Xiang Z; Daniels JS; Niswender CM; Jones CK; Lindsley CW; Conn PJ
    Neuropsychopharmacology; 2016 Jan; 41(2):598-610. PubMed ID: 26108886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model.
    Puri V; Wang X; Vardigan JD; Kuduk SD; Uslaner JM
    Behav Brain Res; 2015; 287():96-9. PubMed ID: 25800972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a Novel M1 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator Radioligand, [3H]PT-1284.
    Smith DL; Davoren JE; Edgerton JR; Lazzaro JT; Lee CW; Neal S; Zhang L; Grimwood S
    Mol Pharmacol; 2016 Sep; 90(3):177-87. PubMed ID: 27382013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad analgesic activity of a novel, selective M1 agonist.
    Wood MW; Martino G; Coupal M; Lindberg M; Schroeder P; Santhakumar V; Valiquette M; Sandin J; Widzowski D; Laird J
    Neuropharmacology; 2017 Sep; 123():233-241. PubMed ID: 28623171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Synthesis of γ- and δ-Lactam M
    Davoren JE; Garnsey M; Pettersen B; Brodney MA; Edgerton JR; Fortin JP; Grimwood S; Harris AR; Jenkinson S; Kenakin T; Lazzaro JT; Lee CW; Lotarski SM; Nottebaum L; O'Neil SV; Popiolek M; Ramsey S; Steyn SJ; Thorn CA; Zhang L; Webb D
    J Med Chem; 2017 Aug; 60(15):6649-6663. PubMed ID: 28598634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the Molecular Mechanisms of Action of Novel 4-Phenylpyridine-2-One and 6-Phenylpyrimidin-4-One Allosteric Modulators at the M
    van der Westhuizen ET; Spathis A; Khajehali E; Jörg M; Mistry SN; Capuano B; Tobin AB; Sexton PM; Scammells PJ; Valant C; Christopoulos A
    Mol Pharmacol; 2018 Jul; 94(1):770-783. PubMed ID: 29691279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation of a novel positive allosteric modulator of metabotropic glutamate receptor subtype 5 contributes to seizure-like adverse events in rats involving a receptor agonism-dependent mechanism.
    Bridges TM; Rook JM; Noetzel MJ; Morrison RD; Zhou Y; Gogliotti RD; Vinson PN; Xiang Z; Jones CK; Niswender CM; Lindsley CW; Stauffer SR; Conn PJ; Daniels JS
    Drug Metab Dispos; 2013 Sep; 41(9):1703-14. PubMed ID: 23821185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-495, a novel low cooperative M
    Mandai T; Sako Y; Kurimoto E; Shimizu Y; Nakamura M; Fushimi M; Maeda R; Miyamoto M; Kimura H
    Pharmacol Res Perspect; 2020 Feb; 8(1):e00560. PubMed ID: 31990455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.